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In 2012 more than 226,870 new cases of invasive breast cancer will be
diagnosed (1). In the 1970s the connec@on was ﬁrst made between
cancer and virus infec@on. One par@cular virus that has been associated
with breast cancer is human cytomegalovirus (HCMV). This virus is
endemic in the human popula@on and establishes life@me latency in the
host.

cmvIL‐10 upregulates the hIL‐10 receptor

MDA breast cancer cells treated with cmvIL‐10 exhibit upregula@on of the
IL‐10 receptor on the cell surface as compared to untreated cells.
Furthermore, MDA cells express Stat3 protein which becomes
phosphorylated and ac@vated by the binding of cmvIL‐10 to the IL‐10
receptor.

Here, we show that cmvIL‐10 ac@vates Stat3 in human breast cancer cells
through phosphoryla@on (pStat3). Stat3 has been iden@ﬁed as a key
factor in tumor progression and evasion of programmed cell death (4).
These results suggest that the cmvIL‐10 protein may cause breast cancer
cells to become more invasive or metasta@c.
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To further examine the role of cmvIL‐10 in the progression of breast
cancer, PCR arrays will be used to evaluate resul@ng changes in gene
expression. Genes encoding adhesion factors and extracellular enzymes
are of par@cular interest, as they play a crucial role in dissemina@on of
cancer cells and the establishment of secondary tumors. Addi@onal follow
up experiments will include ELISAs to monitor enzymes levels and
migra@on assays to evaluate invasive poten@al.
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HCMV infected cells produce cmvIL‐10 protein, a viral homolog of the
human interleukin‐10 protein (hIL‐10), which ac@vates the JAK‐STAT
signaling pathway (2). Like hIL‐10, cmvIL‐10 has also been shown to bind
to the IL‐10 receptor and ac@vate the JAK‐STAT pathway as well (3).

‐ cmvIL‐10

Fluorescence Intensity

Fluorescence Intensity

Figure 2. IL‐10 receptor levels examined by ﬂow cytometry. MDA‐MB‐231 human breast
cancer cells were serum starved for 24 hours and treated with 100ng/mL of puriﬁed
recombinant cmvIL‐10 protein for 15 min. The green represents the IL‐10 receptor
labeled with the an@‐IL‐10 receptor an@body. The black represents the control an@body.
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Figure 1. Paracrine eﬀects of cmvIL‐10 protein. Virus infected cells release
cmvIL‐10 protein which acts on nearby cells that have the IL‐10 receptor.

Figure 3. Western blot showing Stat3 ac.va.on by cmv IL‐10. MDA‐MB‐231 cells were
treated with cmvIL‐10. The cells were lysed, lysates clariﬁed and the proteins separated
on SDS‐PAGE gel. The proteins were then transferred to a membrane and probed with
an@‐Stat3 and pStat3 an@bodies.

If cmvIL‐10 does eﬀect these cellular changes, this might suggest that
HCMV posi@ve cancer pa@ents would beneﬁt from an@‐viral therapy
combined with tradi@onal chemotherapy. Our results are expected to
clarify the role of HCMV in breast cancer and could have signiﬁcant
implica@ons for pa@ent treatment strategy.
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